Institutional Biosafety Committee



The Institutional Biosafety Committee (IBC) is a University-wide group Committee responsible for reviewing and approving recombinant or synthetic nucleic acid molecules research and biohazard research projects. The IBC has overall oversight responsibility for the Biosafety Program at Boston University and Boston Medical Center. The IBC carries out these functions pursuant to requirements set forth by federal, state, and local agencies as well as Boston University.

View the latest IBC Minutes and Meeting Dates & Deadlines.

View the latest IBC Newsletter.

How to:

Submit a New Application to the IBC

Complete the Training Requirement(s)

Receive Clearance from ROHP

Complete an AmendmentAnnual Renewal and/or Three-Year Renewal

Print my Approval Documentation

Check for Regulatory Updates and IBC News:

Resources and Regulatory Updates